3 dirt cheap growth shares to buy right now?

Forget investing in defensive stocks during market weakness, I reckon this is a great time to buy some cheap growth shares.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Silhouette of a bull standing on top of a landscape with the sun setting behind it

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

So the FTSE 100 has been falling, amid fears of a crash. Time to hunker down and stick to dull-but-safe shares? Nah, I see some top growth shares out there at low prices.

Growth stocks can be volatile in a slump though. And the risk is that the bottom can be hard to spot.

So fallen growth shares might still have a lot further to go. On that cheery thought, here are three I like the look of.

Growth reset

Alliance Pharma (LSE: APH) acquires and markets pharmaceutical products, and it brought in the growth investors.

The shares more than doubled in the five years to March 2022. But then the wheels came off, and they crashed.

Since that share price reset, we’ve had a modest recovery. And I think I see more to come.

FY22 results are due on 21 March, and the firm reckons they’ll be decent. The board says it expects cash flow to “build strongly in 2023“. That should help get debt down and reduce one of the main risks.

The City expects a price-to-earnings (P/E) ratio of 19. But earnings growth could drop that to around 12 by 2024.

If the results don’t impress, we could see more weakness. But if they do, might we see a new bull run?

IT services

Computacenter (LSE: CCC) put on a bit of a growth spurt in the Covid years. The work-from-home thing was a big help on that score.

The share price has since fallen back again though. I do think it got a bit too hot, but it looks to me like it’s cooled a bit too far now.

We’re looking at P/E multiples of only around 13. And that’s for a company that reckons it still has solid growth potential in the coming years.

The tough global economic conditions might well hold it back in 2023. And I suspect we could see some more price weakness.

Results are due on 20 March, and I think they might give the shares a boost.

Drug development

Ergomed (LSE: ERGO) is my third pick. This time, the share price hasn’t had a big fall. And it’s on a high valuation more in line with some typical growth shares. But I think it might be worth it.

The shares have soared by 500% over the past five years. Gulp! But at least they’ve eased off a bit since the start of 2023.

Forecasts put the P/E at over 30, and that might look a bit high. But it could fall to the low 20s by 2024. Results are due on 21 March, so we should get an idea of how things look.

The last update spoke of a 22.5% revenue growth. The order book is up 23% too. Oh, and there’s no debt.

Hmm, I almost forgot what the firm does. It provides a range of clinical services to big pharma companies around the world. That could be a big win.

I think this is the biggest risk of the three, but I like it. I need to dig deeper.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended Alliance Pharma Plc and Ergomed Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

The FTSE 100’s newest member looks like a no-brainer to me!

This Fool explains why she sees the newest member of the FTSE 100 as a great opportunity after its recent…

Read more »

Investing Articles

Empty Stocks and Shares ISA? Here’s how I’d start earning a second income from scratch

Like the thought of earning extra cash tax free? Our writer explains what he'd do to begin earning passive income…

Read more »

Happy young female stock-picker in a cafe
Investing Articles

No savings at 25? I’d start by investing £3k in these 3 red-hot FTSE 100 shares

Harvey Jones thinks these three FTSE 100 stocks would be a great way to kickstart a portfolio of UK shares.…

Read more »

Young Black woman using a debit card at an ATM to withdraw money
Investing Articles

Up 35% from this year’s low! Here’s where I think Lloyds shares are headed in H2 of 2024

My Lloyds shares are already doing well this year but that’s not guaranteed to continue. What factors could turn the…

Read more »

Investing Articles

Approaching £5, is there still growth ahead for the Rolls-Royce share price?

The Rolls-Royce share price has been flying in the last year. But is there more growth ahead or should investors…

Read more »

Happy young plus size woman sitting at kitchen table and watching tv series on tablet computer
Investing Articles

Could Raspberry Pi be a growth share to buy and hold?

Our writer explains why he thinks a newly-listed UK growth share could have a bright future -- and considers whether…

Read more »

A pastel colored growing graph with rising rocket.
Market Movers

The FTSE 100 jumps after the Bank of England meeting. Here’s what’s next

Jon Smith runs over the takeaways from the Bank of England meeting today and flags up which FTSE 100 stocks…

Read more »

Middle-aged white male courier delivering boxes to young black lady
Investing Articles

How I’d start investing in great value UK shares with £10,000 today

Harvey Jones can see a heap of UK shares he'd like to add to an ISA today. Many combine low…

Read more »